Homology Medicines (FIXX) Peer Comparison

$0.89

$-15.80 (-94.66%)

As on 25-Mar-2024 18:27EDT

Market cap

$3 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Edit

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Market cap ($ Mln)	3	185
Revenue ($ Mln)	1	--
Net Profit ($ Mln)	-112.96	-124.65
Net Margin (%)	-2,731.17	-957.77
RoE (%)	-90.02	-51.95
Price to Earnings	--	--
Price-To-Book	0.04	1.01

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Operating Revenue	1.16	0.00
Cost of Revenue	0.58	2.41
Gross Profit	0.58	-2.41
Operating Expenses	92.68	70.70
Operating Profit (EBIT)	-92.10	-73.11
Other Income	--	--
Profit before Tax	-87.08	-124.65
Provision for Tax	25.88	--
Profit after Tax (Net Income)	-112.96	-124.65
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities ($ Mln)

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Shareholder's Funds	72.99	183.58
Minority Interest	--	--
Non-Current Liabilities	221.55	0.08
Current Liabilities	11.57	4.80
Total Liabilities	306.12	188.46

Assets ($ Mln)

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Non-Current Assets	222.21	0.44
Current Assets	83.91	188.02
Total Assets	306.12	188.46
Total Debt*	1.32	0.36
Net Current Assets	72.34	183.22

Cashflow ($ Mln)

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Cash From Operating Activities	-96.23	-90.01
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	0.18	0.19
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
ROCE (%)	-80.18	-51.29
ROE (%)	-90.02	-51.95
ROA (%)	-42.26	-48.85
EBIT Margin (%)	--	--
Net Margin (%)	-9,771.71	--
Cash Profit Margin (%)	--	--

Growth Ratios

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Revenue Growth (%)	-0.64	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	-23,487.37	-29.22
EPS Growth (%)	-232.73	-0.24
Book Value Growth (%)	--	--

Valuation Ratios

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Price / Earnings	-0.31	-1.22
Price / Book Value	0.48	0.83
Dividend Yield (%)	--	--
EV/EBITDA	0.50	0.47
Market Cap ($ Cr)	--	--

Solvency Ratios

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Debt to Equity	0.02	0.00
Short term debt to equity ratio	0.02	0.00
Current Ratio	7.25	39.20
Quick Ratio	--	--
Interest Coverage	--	--

Operating Efficiency Ratios

	Homology Medicines (FIXX)	Graphite Bio Inc (GRPH)
Debtors to sales (%)	--	--
Asset Turnover	0.00	0.00
Receivable days	94.79	--
Inventory Days	--	--
Payable days	1,383.27	216.84
Cash Conversion Cycle	--	--

Annual
Quarterly